Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Intracellular delivery of full-length antibodies via organ-targeted lipid nanoparticles.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Phosphoserine as an Alternative Energy Source for <i>E. coli</i> Cell-Free Protein Synthesis with Increased Yield and Prolonged Activity.

ACS synthetic biology·2026
Same author

Blindness to minority absence.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Music enhances lipid nanoparticle brain delivery and mRNA transfection in brain cells.

Journal of controlled release : official journal of the Controlled Release Society·2025
Same author

AI-Validated Brain Targeted mRNA Lipid Nanoparticles with Neuronal Tropism.

ACS nano·2025
Same author

Usage of time multiplexing super resolution for imaging through scattering medium.

Optics express·2025

Related Experiment Video

Updated: May 16, 2025

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System
08:00

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System

Published on: May 14, 2015

31.5K

Scaling Up Synthetic Cell Production Using Robotics and Machine Learning Toward Therapeutic Applications.

Noga Sharf-Pauker1,2, Ido Galil3, Omer Kfir1

  • 1The Louis Family Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies, Department of Chemical Engineering, Technion - Israel Institute of Technology, Haifa, 32000, Israel.

Advanced Biology
|March 31, 2025
PubMed
Summary
This summary is machine-generated.

Researchers developed an automated method for producing synthetic cells (SCs) for therapeutic uses. This innovation enhances scalability and efficiency, paving the way for advanced biomedical applications.

Keywords:
AIartificial Intelligenceautomationmachine learningroboticssynthetic biologysynthetic cells

More Related Videos

Preparing Protein Producing Synthetic Cells using Cell Free Bacterial Extracts, Liposomes and Emulsion Transfer
09:37

Preparing Protein Producing Synthetic Cells using Cell Free Bacterial Extracts, Liposomes and Emulsion Transfer

Published on: April 27, 2020

10.9K
Automated Production of Human Induced Pluripotent Stem Cell-Derived Cortical and Dopaminergic Neurons with Integrated Live-Cell Monitoring
09:34

Automated Production of Human Induced Pluripotent Stem Cell-Derived Cortical and Dopaminergic Neurons with Integrated Live-Cell Monitoring

Published on: August 6, 2020

7.1K

Related Experiment Videos

Last Updated: May 16, 2025

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System
08:00

Scalable 96-well Plate Based iPSC Culture and Production Using a Robotic Liquid Handling System

Published on: May 14, 2015

31.5K
Preparing Protein Producing Synthetic Cells using Cell Free Bacterial Extracts, Liposomes and Emulsion Transfer
09:37

Preparing Protein Producing Synthetic Cells using Cell Free Bacterial Extracts, Liposomes and Emulsion Transfer

Published on: April 27, 2020

10.9K
Automated Production of Human Induced Pluripotent Stem Cell-Derived Cortical and Dopaminergic Neurons with Integrated Live-Cell Monitoring
09:34

Automated Production of Human Induced Pluripotent Stem Cell-Derived Cortical and Dopaminergic Neurons with Integrated Live-Cell Monitoring

Published on: August 6, 2020

7.1K

Area of Science:

  • Synthetic Biology
  • Biotechnology
  • Cellular Engineering

Background:

  • Current synthetic cell (SC) production is largely manual, hindering scalability and efficiency for therapeutic applications.
  • Manual SC synthesis and characterization limit the potential of bottom-up synthetic biology in medicine.
  • There is a need for automated, high-throughput methods for SC production and quality control.

Purpose of the Study:

  • To develop an automated method for large-scale production of protein-producing synthetic cells (SCs) for therapeutic applications.
  • To optimize SC synthesis and characterization processes for improved efficiency, scalability, and quality control.
  • To demonstrate the feasibility of automated SCs in preclinical settings.

Main Methods:

  • Developed an automated process compatible with robotic liquid handling systems (LiHa) for SC synthesis.
  • Incorporated an automated tissue dissociator for enhanced emulsification and increased batch size.
  • Employed artificial intelligence (AI)-based image analysis for automated, high-throughput SC characterization and quality assessment.
  • Administered large-scale, homogeneous batches of luciferase-expressing SCs to mice for in vivo protein expression monitoring.

Main Results:

  • Reduced SC production time by 50% through process optimization.
  • Increased SC batch size by 30-fold using automated emulsification, while maintaining SC characteristics.
  • Achieved automated, accurate, and high-throughput SC characterization using AI-based image analysis.
  • Demonstrated real-time monitoring of protein expression in vivo, reducing experimental variability.

Conclusions:

  • Automation and computerized quality control significantly improve synthetic cell synthesis.
  • The developed automated method enhances scalability and efficiency for producing therapeutic SCs.
  • This approach facilitates the advancement of synthetic cells for preclinical and clinical applications.